Altasciences Featured Articles
-
Overcoming Solubility Challenges With Nanomilling
1/5/2024
Explore why this highly complex process requires a unique level of CDMO expertise that can only be gained through extensive experience with developing a broad range of APIs.
-
Ensure Sterility: Terminal Sterilization Of Pharmaceutical Products
1/5/2024
Discover the full benefits of terminal sterilization, how it differs from aseptic manufacturing, and its level of compatibility with your product. Case study included.
-
Maximizing Drug Formulations For First-In-Human Trials
1/5/2024
Discover how drug formulation strategies in first-in-human trials impact safety, dosing, and regulatory success, with case studies highlighting integrated development and manufacturing approaches.
-
One Integrated Solution For Meeting Early Drug Development Needs
1/26/2023
Over 143 executives of biopharmaceutical companies provided insights in a survey to understand the challenges they face when outsourcing their early phase drug development programs.
-
Ophthalmic End-To-End Drug Development Solutions
1/26/2023
Overcome challenges and complexities in ophthalmic drug development by partnering with an integrated CRO/CDMO provider with extensive regulatory knowledge and scientific expertise.
-
The Complexities Of Early Phase Ophthalmic Drug Development
1/26/2023
Discover how the complexity and challenges of bringing ophthalmic therapeutics to market can be mitigated by entrusting your drug development program to an integrated CRO/CDMO partner.